Dr. Joseph Giancola joined U.S. Dermatology Partners, formerly Southwest Skin Specialists, in 1997. After attaining his undergraduate degree from Creighton University in 1986, Dr. Joseph Giancola graduated with honors from the University of Missouri-Columbia School of Medicine in 1990. His postgraduate training included an internship and residency in internal medicine at Good Samaritan Regional Medical Center in Phoenix and a residency in dermatology at the University of Arizona. He completed a Mohs surgical fellowship with Dr. George Hruza at the Laser and Dermatologic Surgery Center in St. Louis in 2001.
Dr. Joseph Giancola specializes in Mohs surgery and cutaneous oncology. In addition to being an associate professor at Creighton University School of Medicine, he lectures at the University of Arizona College of Medicine and volunteers at the dermatology clinic at St. Vincent De Paul in Phoenix.
Dr. Giancola provides dermatology care to patients in Phoenix, Arizona.
Basal Cell Carcinoma, also known as basalioma or basal cell cancer, is the most common type of skin cancer and carries the least amount of risk, though it still requires attention. If caught and treated early, basal cell carcinomas are not likely to be life-threatening, but they do have the potential to cause disfigurement of the skin tissue.
Almost one million new cases of basal cell carcinoma are diagnosed each year in the U.S., and up to 30% of Caucasians may develop basal cell carcinomas in their lifetime.
Skin cancer is considered low risk when the affected cells remain clustered in a single group. Both basal cell carcinoma and squamous cell carcinoma are rarely life-threatening. Though it is unlikely to spread to other parts of your body, if left untreated, basal cell carcinoma can move into nearby bone or other tissue.
Basal cell carcinoma typically begins as a small, shiny bump on the face, although it can occur on any part of the body.
Melanoma, the deadliest of skin cancers, only accounts for about 4 percent of all skin cancer cases, but causes about 79 percent of skin cancer deaths.
Melanoma is a cancer of the skin that begins in the melanocytes, which are the cells that produce the pigment melanin. It is the leading cause of cancer death in women 25 to 30 years old and the second leading cause of cancer death in women 30 to 35 years old.
In some cases, melanoma occurs in melanocytes throughout the body, even if those parts have never been exposed to the sun.
Mohs surgery offers the highest cure rates for all non-melanoma skin cancers. For certain cases of the most common types of skin cancer — squamous cell carcinoma and basal cell carcinoma — the cure rate can be as high as 99 percent.
Mohs surgery is a highly specialized surgical technique used to treat non-melanoma skin cancers in which the surgeon removes all of the visible cancer, plus a small margin of the surrounding healthy tissue and examines it to ensure that all cancer cells have been removed at the time of surgery.
During Mohs micrographic surgery — named after Dr. Frederic Mohs, who first performed it in the 1930s — cancer is removed from the skin layer by layer until all cancerous cells have been removed. This type of surgery is most commonly used for cancers that have a high risk of re-occurrence. This technique allows for complete removal of the skin cancer while minimizing the removal of surrounding healthy skin.
Skin cancer is the most common form of cancer in the U.S. with more than 3.5 million cases diagnosed each year.
Skin cancer is the result of uncontrolled growth of abnormal skin cells that takes place when skin cells suffer DNA damage and then mutate, causing them to multiply rapidly and form malignant (cancerous) tumors. Most skin cancers develop on the visible outer layer of the skin (the epidermis), particularly on sun-exposed areas such as the face, head, hands, arms and legs. They are usually easy to detect with a skin examination, which increases the chances of early diagnosis.
There are different types of skin cancer, each named for the type of skin cell from which they originate. The most common type of skin cancer is basal cell carcinoma. Almost one million new cases of basal cell carcinoma are diagnosed each year in the U.S. Most skin cancers fall into one of three categories:
There are often warning signs that cancer is developing. The most common are pre-cancerous lesions called actinic keratoses that often develop on sun-exposed areas. These tumors replace normal surrounding tissue and generally do not spread to other areas.
Skin cancer is considered low risk when the affected cells remain clustered in a single group. Both basal cell carcinoma and squamous cell carcinoma are rarely life-threatening.
Skin cancer is considered a high risk when cells have invaded surrounding tissues. The third most common skin cancer, malignant melanoma, can be life-threatening if not diagnosed and treated early.
If skin cancer is detected before it has spread to surrounding tissues, the chances of a complete recovery and cure are excellent. High-risk forms of cancer like melanoma require more aggressive treatments.
Squamous Cell Carcinoma is a common form of skin cancer that develops in the squamous cells that make up the outer layer of the skin. Although it is usually not life-threatening, it can be aggressive in some cases.
If left untreated, squamous cell carcinoma can grow large or spread to other parts of your body, causing serious complications.
Telemedicine, also known as online dermatology, telehealth, or teledermatology, is the use of telecommunications technology to provide care across a distance. This includes using the Internet, cell phones, SMS messaging and even satellites to allow physicians and patients to communicate medical information. This technology has been available for over a decade now, but as it has gotten better and better, telemedicine has now become much more available, easy to use, and secure. If used in the right way, it is one of the best ways that we can improve access to care.
Because dermatology is a very visual field and a specialty in high demand, patient access is often challenged by long wait times. Meeting a dermatologist online can be a great way to provide patients with increased access to skin care. Teledermatology involves the use of real-time video streaming, or more commonly the transmission of still images, pictures, and video in combination with a patient’s medical information collected via questionnaire. Teledermatology can be utilized in many ways including physician-to-physician consultations, triage, follow-up care, and patient education.
The sun can age and burn your skin, and it can also cause damage on the cellular level, leading to skin cancer. The good news is, the U.S. Dermatology Partners team can help you formulate a plan to prevent sun damage and repair the effects of the sun’s UV rays so that you can go out and enjoy a sunny day. Learn more on this page or contact U.S. Dermatology Partners to schedule an appointment with us.
Individuals who are prone to sunburn are thought to be genetically predisposed to skin cancer. Risk is also increased when exposure to UV rays is excessive. Sunscreen helps prevent the damaging effects of ultraviolet radiation, including skin aging and skin cancer like melanoma and squamous cell carcinoma.
Sunscreens are rated and labeled with a sun protection factor (SPF) that measures the fraction of sunburn-producing UV rays that reach the skin. The higher the SPF, the greater the protection.
Keloids are raised, red scars created by excessive healing of skin wounds, such as burns, cuts and acne. They are the result of an overproduction of collagen as the skin tries to repair itself. Keloids also can occur after piercings, tattoos or surgery and often times are itchy and painful. They can grow for years and sometimes show up three months or longer after the injury occurred.